erdafitinib
janssen
['bladder', 'urothelial', 'erdafitinib']
erdafitinib reduces risk of death by 36% in fgfr-altered urothelial cancer #oncology #nursing #bladdercancer #asco23 
Capturing the voice of nursing professionals in the oncology news landscape.